Galapagos – Talk Bio

Catalent and Galapagos Collaborate on Decentralized CAR-T Manufacturing; Kindeva Secures $129M Contract for Nerve Agent Antidote

3 months ago talkbio0Tagged Antidote, CAR-T, Catalent, decentralized, Duodote, Galapagos, Kindeva, Lymphoma, Non-Hodgkin, Manufacturing, Nerve Agents, NHL, Strategic National Stockpile

Catalent, Galapagos, CAR-T therapy, Decentralized manufacturing, Non-Hodgkin lymphoma (NHL), Kindeva Drug Delivery, DuoDote, Nerve agent antidote, Strategic National Stockpile

CARsgen and Galapagos Resume CAR-T Trials Without Restrictions

6 months ago talkbio0Tagged Cancer Therapeutic Procedure, CAR-T trials, CARsgen, Clinical Trials, Galapagos

CAR-T trials, CARsgen, Galapagos, cancer treatment, clinical trials

Galapagos Investor Seeks to Influence Company Control, Citing Undervaluation

8 months ago talkbio0Tagged Control Groups, Corporate, Galapagos, Influence, investor, Undervaluation

Galapagos, investor influence, undervaluation, biotech, corporate control

Galapagos Halts BCMA CAR-T Study Due to Parkinsonism Case

9 months ago talkbio0Tagged bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine, CAR-T, Clinical Trials, Galapagos, GLPG5301, Multiple Myeloma, PAPILIO-1, Parkinsonian Disorders

Galapagos, BCMA CAR-T, Parkinsonism, multiple myeloma, CAR-T therapy, clinical trial, PAPILIO-1 study, GLPG5301

Galapagos Halts CAR-T Cell Therapy Trial Due to Parkinsonism Case

9 months ago talkbio0Tagged BCMA-directed therapy, CAR-T, Cell Therapy, Clinical Trials, Enrollment, Galapagos, Multiple Myeloma, Parkinsonian Disorders

Galapagos, CAR-T cell therapy, Parkinsonism, clinical trial, patient enrollment, BCMA-directed therapy, multiple myeloma

Galapagos Partners with Adaptimmune for $665M T-Cell Therapy Collaboration

11 months ago talkbio0Tagged Adaptimmune, biobucks, Collaboration, financing characteristics, Galapagos, Licensing, Melanoma-Associated Antigen 4, next-generation therapy, T-Cell Receptor, T-cell therapy

Galapagos, Adaptimmune, T-cell therapy, MAGE-A4 TCR, Uza-cel, Biobucks collaboration, Licensing deal, Financing, Next-generation therapy

Galapagos Expands Decentralized CAR-T Manufacturing Across the Nation with Strategic Partnership

11 months ago talkbio0Tagged Biotechnology, Cancer Therapeutic Procedure, CAR-T, decentralized, expansion, Galapagos, healthcare innovation, Immunotherapy, Manufacture, nationwide, Partnership

Galapagos, decentralized CAR-T manufacturing, partnership, nationwide expansion, cancer treatment, immunotherapy, biotechnology, healthcare innovation.